← Leaderboards
Lindsey Robert Baden
Brigham And Women'S Hospital
$8,253,212
Attributed
$23,655,046
Total exposure
3
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $6.2M · FY2010–25$10M$7.5M$5M$2.5M$0
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$23,655,046 · 3
By mechanism
UM1$21,445,869 · 1
U01$1,673,641 · 1
R21$535,536 · 1
Top collaborators
- Daniel R Kuritzkes6 shared
- Kenneth H Mayer6 shared
- James Comolli2 shared
- David James Dowling1 shared
Most similar at Brigham And Women'S Hospital
Same institution · by research overlap
- Hadi Shafiee$15,983,059
- Sophia Koo$15,534,982
- Daniel R Kuritzkes$313,891,104
- Kenneth H Mayer$64,411,257
- Amy Caryn Sherman$194,400
Others in their field
Top investigators on “Infection”
- Wafaa M. El-Sadr · Columbia University Health Sciences$965,939,185
- Lawrence Corey · Fred Hutchinson Cancer Center$789,608,171
- Judith S. Currier · University Of California Los Angeles$511,038,212
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$463,711,983
- Richard Marlink · Elizabeth Glaser Pediatric Aids Fdn$457,210,249
- Joseph J. Eron · Univ Of North Carolina Chapel Hill$415,229,497
Research focus
InfectionClinical ResearchModalityResponsePhase 1 StudyDesignVaccinesInnovationVaccine CandidateAdjuvantEvaluationOrganAntigensAids PreventionAffectBehavioralAids DiagnosisAreaAids Clinical Trial GroupConduct Clinical TrialsAnti-Retroviral AgentsClinical Trials DesignClinical Research SiteClinical Trials
Grant awards (9)
Boston HIV CTU$4,506,411
UM1 · FY2025 · AI
Phase 1 study of a SARS-CoV-2 vaccine adjuvanted via controlled biodistribution of mRNA encoding spike protein and IL-12p70$1,673,641
U01 · FY2025 · AI
Boston HIV CTU$3,541,665
UM1 · FY2024 · AI
Boston HIV CTU$4,338,234
UM1 · FY2023 · AI
Boston HIV CTU$4,700,628
UM1 · FY2022 · AI
Boston HIV CTU$4,358,930
UM1 · FY2021 · AI
Boston HIV CTU$1
UM1 · FY2021 · AI
Analysis of Exhaled Volatiles for the Diagnosis$241,598
R21 · FY2011 · AI
Analysis of Exhaled Volatiles for the Diagnosis$293,938
R21 · FY2010 · AI